Top Markets
#1 Talus Network Talus Network +32.37%
#2 Brevis Brevis +31.08%
#3 Keep Network Keep Network +29.54%
#4 Tung Tung Tung Sahur Tung Tung Tung Sahur +26.02%
#5 MemeCore MemeCore +25.40%
#6 Starpower Starpower +24.39%
#7 Allora Allora +23.79%
#8 Infinity Ground Infinity Ground +22.19%
#9 QANplatform QANplatform +19.54%
#10 屎壳郎 (Dung Beetle) 屎壳郎 (Dung Beetle) +17.26%
Coin of the day
Talus Network Talus Network
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
IntegraGen SA IntegraGen SA

IntegraGen SA

ALINT
Rang in Aktien #19673
IntegraGen SA provides human genome analysis services for academic researcher... IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. IntegraGen SA is a subsidiary of OncoDNA SA.
Aktienkurs
$0.20876331
Marktkapitalisierung
$1.38M
Veränderung (1 Tag)
1.15%
Veränderung (1 Jahr)
-64.84%
Land
FR
Handel IntegraGen SA (ALINT)

Kategorie

Healthcare
Anzahl der ausstehenden Aktien von IntegraGen SA (ALINT)
Anzahl der ausstehenden Aktien zum December 2025: 6.87M
Laut den neuesten Finanzberichten und dem Aktienkurs von IntegraGen SA beträgt die aktuelle Anzahl der ausstehenden Aktien 6.87M. Am Ende von December 2023 hatte das Unternehmen 6.61M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von IntegraGen SA (ALINT) von 2008 bis 2026
Ausstehende Aktien am Ende jedes Jahres
Jahr Ausstehende Aktien ändert
2026 (TTM) 6.87M 1.95%
2024 6.74M 1.87%
2023 6.61M -0.22%
2022 6.63M 0.14%
2021 6.62M -0.41%
2020 6.65M 2.44%
2019 6.49M 0.35%
2018 6.46M -0.27%
2017 6.48M 29.14%
2016 5.02M -0.17%
2015 5.03M 1.70%
2014 4.94M 20.14%
2013 4.12M 0.00%
2012 4.12M 9.12%
2011 3.77M 0.00%
2010 3.77M 26.93%
2009 2.97M 0.00%
2008 2.97M 0.00%
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
Unternehmen Ausstehende Aktien Unterschied Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 4.44B 64,584.67%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 254.10M 3,599.77%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 104.00M 1,414.27%
US
UCB SA UCB SA
UCB SA
UCB.BR
 190.00M 2,666.41%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 61.42M 794.28%
NL